Faron Pharmaceuticals Oy (GB:FARN) has released an update.
Faron Pharmaceuticals Oy has announced the appointment of Dr. Petri Bono as its new Chief Medical Officer, effective August 15, 2024. Dr. Bono brings a wealth of experience from previous roles, including CMO of Terveystalo and Helsinki University Hospital, and is expected to drive Faron’s innovative immunotherapy program and the development of bexmarilimab, the company’s leading cancer treatment. The company believes Dr. Bono’s expertise will be instrumental in advancing treatments for solid tumors and hematological malignancies.
For further insights into GB:FARN stock, check out TipRanks’ Stock Analysis page.
